MiNA works in collaboration with world leading research organisations across academic institutions and industry partners.
We are seeking new R&D partners in academic research and biopharmaceutical drug development in the following areas:
Opportunities to evaluate pharmacology of MTL-CEBPA as a combination agent in both pre-clinical studies and clinical development including clinical collaborations in immuno-oncology.
Drug discovery opportunities against new disease targets especially in immuno-oncology, immunology and metabolic diseases.
New, scalable, delivery technologies, administered systemically or locally, that can extend the in vivo activity of our saRNA compounds to tissue that are currently inaccessible.
The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.